Table 3 H89 inhibitable kinases expressed in PKA-intact mpkCCD cells.

From: Phosphorylation Changes in Response to Kinase Inhibitor H89 in PKA-Null Cells

Gene

Symbol

Kinase

Family

Relative RNA

Abundance*

Relative Protein

Abundance

In vitro Percent

Inhibition by H89 (10 µM)

Prkacb

AGC

0.64

0.525

99

Rps6kb1

AGC

0.26

0.010

97

Akt1

AGC

3.53

0.122

95

Rps6ka5

AGC

0.22

0.028

95

Rock2

AGC

0.95

0.261

94

Pkn2

AGC

1.01

0.051

94

Rps6ka1

AGC

0.56

0.118

92

Akt2

AGC

0.58

0.024

88

Rps6ka3

AGC

0.17

0.170

81

Chek1

CAMK

0.44

0.004

76

Prkaa1

CAMK

0.64

0.779

74

Mark3

CAMK

1.98

0.061

71

Mink1

STE

0.42

0.001

66

Mark2

CAMK

0.74

0.195

65

Prkcz

AGC

0.24

0.005

65

Melk

CAMK

0.40

62

Cdk2

CMGC

1.37

0.921

59

Aurkb

Other

0.72

55

Map2k2

STE

1.38

0.591

54

Camk1

CAMK

0.69

0.000

53

Stk24

STE

1.09

0.507

51

  1. *RNA abundance normalized by value for PKA catalytic α. From https://hpcwebapps.cit.nih.gov/ESBL/Database/PKA-KO/GeneSymbol.html.
  2. Protein abundance normalized by value for PKA catalytic α. From https://hpcwebapps.cit.nih.gov/ESBL/Database/mpkCCD_Protein_Abundances/.
  3. Percent inhibition of purified enzyme. Data from http://www.kinase-screen.mrc.ac.uk/screening-compounds/341068.
  4. §Upregulated in PKA-null cells.